BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 32149465)

  • 1. Induction of apoptosis through extrinsic/intrinsic pathways and suppression of ERK/NF-κB signalling participate in anti-glioblastoma of imipramine.
    Hsu FT; Chiang IT; Wang WS
    J Cell Mol Med; 2020 Apr; 24(7):3982-4000. PubMed ID: 32149465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluoxetine Induces Apoptosis through Extrinsic/Intrinsic Pathways and Inhibits ERK/NF-κB-Modulated Anti-Apoptotic and Invasive Potential in Hepatocellular Carcinoma Cells In Vitro.
    Chen WT; Hsu FT; Liu YC; Chen CH; Hsu LC; Lin SS
    Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30754643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of human MX2 gene suppresses cell proliferation, migration, and invasion via ERK/P38/NF-κB pathway in glioblastoma cells.
    Wang H; Guan Q; Nan Y; Ma Q; Zhong Y
    J Cell Biochem; 2019 Nov; 120(11):18762-18770. PubMed ID: 31265172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperforin induces apoptosis through extrinsic/intrinsic pathways and inhibits EGFR/ERK/NF-κB-mediated anti-apoptotic potential in glioblastoma.
    Hsu FT; Chen WT; Wu CT; Chung JG
    Environ Toxicol; 2020 Oct; 35(10):1058-1069. PubMed ID: 32485087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of Akt/NF-κB pathway in antitumor effects of parthenolide on glioblastoma cells in vitro and in vivo.
    Nakabayashi H; Shimizu K
    BMC Cancer; 2012 Oct; 12():453. PubMed ID: 23039130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis induction and ERK/NF-κB inactivation are associated with magnolol-inhibited tumor progression in hepatocellular carcinoma in vivo.
    Tsai JJ; Chen JH; Chen CH; Chung JG; Hsu FT
    Environ Toxicol; 2020 Feb; 35(2):167-175. PubMed ID: 31714653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amentoflavone Effectively Blocked the Tumor Progression of Glioblastoma via Suppression of ERK/NF-
    Hsu FT; Chiang IT; Kuo YC; Hsia TC; Lin CC; Liu YC; Chung JG
    Am J Chin Med; 2019; 47(4):913-931. PubMed ID: 31096773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regorafenib induces extrinsic and intrinsic apoptosis through inhibition of ERK/NF-κB activation in hepatocellular carcinoma cells.
    Tsai JJ; Pan PJ; Hsu FT
    Oncol Rep; 2017 Feb; 37(2):1036-1044. PubMed ID: 28000898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of EGFR/PKC-δ/NF-κB Signaling Associated With Imipramine-Inhibited Progression of Non-Small Cell Lung Cancer.
    Yueh PF; Lee YH; Chiang IT; Chen WT; Lan KL; Chen CH; Hsu FT
    Front Oncol; 2021; 11():735183. PubMed ID: 34765548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis induction and AKT/NF-κB inactivation are associated with regroafenib-inhibited tumor progression in non-small cell lung cancer in vitro and in vivo.
    Weng MC; Li MH; Chung JG; Liu YC; Wu JY; Hsu FT; Wang HE
    Biomed Pharmacother; 2019 Aug; 116():109032. PubMed ID: 31163381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperforin Suppresses Tumor Growth and NF-κB-mediated Anti-apoptotic and Invasive Potential of Non-small Cell Lung Cancer.
    Chen WT; Chen YK; Lin SS; Hsu FT
    Anticancer Res; 2018 Apr; 38(4):2161-2167. PubMed ID: 29599335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lenvatinib Inhibits AKT/NF-κB Signaling and Induces Apoptosis Through Extrinsic/Intrinsic Pathways in Non-small Cell Lung Cancer.
    Liu YC; Huang BH; Chung JG; Liu WL; Hsu FT; Lin SS
    Anticancer Res; 2021 Jan; 41(1):123-130. PubMed ID: 33419805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regorefenib induces extrinsic/intrinsic apoptosis and inhibits MAPK/NF-κB-modulated tumor progression in bladder cancer in vitro and in vivo.
    Chiang CH; Chung JG; Hsu FT
    Environ Toxicol; 2019 Jun; 34(6):679-688. PubMed ID: 30801954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regorafenib Reverses Temozolomide-Induced CXCL12/CXCR4 Signaling and Triggers Apoptosis Mechanism in Glioblastoma.
    Chiang IT; Liu YC; Liu HS; Ali AAA; Chou SY; Hsu TI; Hsu FT
    Neurotherapeutics; 2022 Mar; 19(2):616-634. PubMed ID: 35267171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of PKCδ/NF-κB Signaling and Apoptosis Induction through Extrinsic/Intrinsic Pathways Are Associated Magnolol-Inhibited Tumor Progression in Colorectal Cancer In Vitro and In Vivo.
    Su CM; Weng YS; Kuan LY; Chen JH; Hsu FT
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32429376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regorafenib inhibits tumor progression through suppression of ERK/NF-κB activation in hepatocellular carcinoma bearing mice.
    Weng MC; Wang MH; Tsai JJ; Kuo YC; Liu YC; Hsu FT; Wang HE
    Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29535278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin-induced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of IkappaB kinase and nuclear factor kappaB activity and are independent of the B-Raf/mitogen-activated/extracellular signal-regulated protein kinase pathway and the Akt pathway.
    Siwak DR; Shishodia S; Aggarwal BB; Kurzrock R
    Cancer; 2005 Aug; 104(4):879-90. PubMed ID: 16007726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imipramine Inhibits Migration and Invasion in Metastatic Castration-Resistant Prostate Cancer PC-3 Cells via AKT-Mediated NF-κB Signaling Pathway.
    Lim EY; Park J; Kim YT; Kim MJ
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33050597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin inhibits H2O2-induced invasion and migration of human pancreatic cancer via suppression of the ERK/NF-κB pathway.
    Cao L; Liu J; Zhang L; Xiao X; Li W
    Oncol Rep; 2016 Oct; 36(4):2245-51. PubMed ID: 27572503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of NF-κB Pathway and Modulation of MAPK Signaling Pathways in Glioblastoma and Implications for Lovastatin and Tumor Necrosis Factor-Related Apoptosis Inducing Ligand (TRAIL) Combination Therapy.
    Liu PC; Lu G; Deng Y; Wang CD; Su XW; Zhou JY; Chan TM; Hu X; Poon WS
    PLoS One; 2017; 12(1):e0171157. PubMed ID: 28135339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.